(a) Name of Issuer:
Heliogen, Inc.
(b) Address of Issuer’s Principal Executive Offices:
130 West Union Street
Pasadena, California 91103
(a) Name of Persons Filing:
Nant Capital LLC (“Nant Capital”), California Capital Equity, LLC (“Cal Cap”) and Patrick Soon-Shiong. Cal Cap directly owns all of the equity interests of Nant Capital. Dr. Soon-Shiong directly owns all of the equity interests of Cal Cap and has voting and dispositive power over shares held by Nant Capital. Cal Cap owns all of the equity interests in Nant Capital and thus may be deemed to control Nant Capital. Dr. Soon-Shiong is the sole member of Cal Cap and thus may be deemed to control Cal Cap. Each of Nant Capital, Cal Cap and Dr. Soon-Shiong may be referred to herein as a “Reporting Person.”
(b) Address of Principal Business Office or, if none, Residence:
9922 Jefferson Boulevard
Culver City, CA 90232
(c) Citizenship:
Nant Capital and Cal Cap are limited liability companies organized under the laws of State of Delaware. Dr. Soon-Shiong is a U.S. citizen.
(d) Title of Class of Securities:
Common Stock, $0.0001 par value per share
(e) CUSIP Number:
42329E105
Item 3. | If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: |
Not applicable.
(a) Amount beneficially owned:
Nant Capital may be deemed to beneficially own an aggregate of 24,646,323 shares of the Issuer’s common stock.
Cal Cap may be deemed to beneficially own an aggregate of 24,646,323 shares of the Issuer’s common stock.
Dr. Soon-Shiong may be deemed to beneficially own an aggregate of 25,657,986 shares of the Issuer’s common stock.
(b) Percent of class:
13.4%-Nant Capital
13.4%-Cal Cap
14.0%-Dr. Soon-Shiong
Each of the ownership percentages above is calculated by dividing (a) the total number of shares of the Issuer’s common stock being reported in this Statement for the respective Reporting Person by (b) the number of shares of the Issuer’s common stock outstanding on December 30, 2021 (183,367,037), based on information publicly disclosed by the Issuer.
Page 5 of 8